Congleton Jon (CIK 0001644975)

Latest company ownership

Shares held
24,082
Last filed at
Nov 24, 2025
Confidence Score
20.0
2025Q4
Confidence Score History
2023Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 11, 2025 Nov 13, 2025 Mineralys Therapeutics, Inc. CEO Sell 16.3 -200,000 -24.06% ✗ $9.1M
Oct 13, 2025 Oct 15, 2025 Mineralys Therapeutics, Inc. CEO Sell 42.5 -15,100 -1.78% ✓ $644.3K
Jul 11, 2025 Jul 15, 2025 Mineralys Therapeutics, Inc. CEO Sell 45.0 -15,884 -1.84% ✓ $230.4K
Apr 11, 2025 Apr 15, 2025 Mineralys Therapeutics, Inc. CEO Sell 45.0 -15,319 -1.75% ✓ $186.8K
Jan 13, 2025 Jan 15, 2025 Mineralys Therapeutics, Inc. CEO Sell 41.3 -18,333 -2.05% ✓ $166.1K
Oct 11, 2024 Oct 15, 2024 Mineralys Therapeutics, Inc. CEO Sell 45.0 -15,271 -1.68% ✓ $206.4K
Jul 11, 2024 Jul 12, 2024 Mineralys Therapeutics, Inc. CEO Sell 45.0 -15,746 -1.70% ✓ $210.1K
Jun 17, 2024 Jun 20, 2024 Mineralys Therapeutics, Inc. CEO Sell 30.0 -49,313 -5.05% ✓ $592K
Jun 12, 2024 Jun 14, 2024 Mineralys Therapeutics, Inc. CEO Sell 30.0 -72,797 -6.94% ✓ $924.2K
Nov 22, 2023 Nov 27, 2023 Mineralys Therapeutics, Inc. CEO Buy 61.3 +4,250 0.41% ✗ $25.4K
Sep 6, 2023 Sep 8, 2023 Mineralys Therapeutics, Inc. CEO Buy 61.3 +2,250 0.22% ✗ $27.2K
Aug 17, 2023 Aug 21, 2023 Mineralys Therapeutics, Inc. CEO Buy 61.3 +2,250 0.22% ✗ $27.2K
Aug 11, 2023 Aug 11, 2023 Mineralys Therapeutics, Inc. CEO Buy 56.3 +2,000 0.19% ✗ $25.8K